Yoga and Cardiometabolic Health: A Meta-Analytical Insight into Benefits for Adults with Overweight and Obesity
In the quest for effective, accessible health interventions, yoga has captured global interest not only as a practice for mental well-being but increasingly as a potential modality for improving physical health metrics, particularly among adults grappling with overweight or obesity. A comprehensive meta-analysis published in PLOS Global Public Health has shed new light on how yoga might influence cardiometabolic health parameters in this demographic, drawing from a substantial corpus of randomized controlled trials. This investigative synthesis, led by Widya Wasityastuti and colleagues from the University of Edinburgh and international collaborators, encompasses 30 studies with 2,689 participants predominantly from Asia, but also from Western countries including the United States, Germany, and Australia. Their systematic review unpacks measurable improvements in blood pressure and cholesterol profiles that could have meaningful implications for cardiovascular risk management.
The significance of this meta-analysis is anchored by its focus on adults identified as overweight or obese according to country-specific body mass index (BMI) thresholds — a criterion critical for targeting populations at elevated risk for cardiometabolic diseases. Specifically, the authors included studies conducted on participants with BMIs over 23 kg/m² in Asian countries and over 25 kg/m² elsewhere, reflecting ethnic variations in adiposity and its related health risks. In collation, 23 of the 30 studies were based in Asian settings, indicating a preliminary regional skew, which the authors acknowledge as a limitation in extrapolating results globally.
Physiologically, cardiometabolic health encompasses a constellation of factors including blood pressure levels, lipid metabolism, glycemic control, systemic inflammation, and antioxidant defenses—parameters routinely implicated in the pathogenesis of cardiovascular and metabolic disorders. The meta-analysis concentrated on these endpoints, rigorously quantifying the effects of yoga interventions on systolic and diastolic blood pressure, lipid fractions such as low- and high-density lipoproteins (LDL and HDL), blood glucose metrics, inflammatory markers, and antioxidant status. Strikingly, the featured studies consistently illustrated a statistically significant average decrease of 4.35 mmHg in systolic blood pressure and 2.06 mmHg in diastolic blood pressure among yoga practitioners compared to controls. These findings are clinically relevant, as even modest reductions in blood pressure are recognized to lower the incidence of stroke and cardiovascular events at the population level.
Beyond blood pressure, the analysis revealed beneficial modulations in lipid profiles—specifically, modest improvements in LDL and HDL cholesterol levels that underpin atherogenic risk. This is a pivotal discovery given the complex interplay of lipid imbalances in the development and progression of ischemic heart disease and stroke in overweight and obese individuals. Improvements in cholesterol, combined with blood pressure reduction, can contribute synergistically to mitigate the heightened cardiovascular risk profile inherent to excess adiposity.
Despite these encouraging findings, the meta-analysis emphasizes the absence of dose-response data, underscoring a significant gap in understanding the optimal frequency, duration, and intensity of yoga practice necessary to achieve these health benefits. Most included studies advocated for a minimum of 180 minutes of yoga per week, yet heterogeneity in protocols and styles—including variations in asana (posture) practice, pranayama (breathing exercises), and meditation components—renders it challenging to distill a standardized regimen for clinical application.
Moreover, the exclusion of study participants with comorbidities such as diabetes and established cardiovascular disease narrows the generalizability of the results. The participants were largely free from significant concurrent illnesses, which means the effect sizes observed might differ in populations with more complex health profiles. The geographical concentration on Asian populations further necessitates caution before universalizing these findings to diverse ethnic groups with varying genetic and environmental susceptibilities.
Crucially, the nature of meta-analytical research restricts causal inferences; the observed associations, while compelling, do not confirm yoga as a causal agent of the cardiometabolic improvements documented. Confounding factors, including lifestyle modifications and concurrent therapies within individual studies, might have influenced outcomes. The authors articulate this limitation clearly and advocate for methodologically robust, randomized, and ideally blinded clinical trials to definitively quantify the health impacts and underlying mechanisms.
Mechanistic hypotheses regarding yoga’s benefits on cardiometabolic health are multifaceted. Yoga’s holistic approach incorporates physical activity through postural exercises, which can enhance cardiovascular endurance and muscular strength. Simultaneously, controlled breathing and meditation may attenuate stress-induced sympathetic nervous system activation, lowering circulating catecholamines that elevate blood pressure. Additionally, yoga’s known influence on inflammatory pathways and oxidative stress may contribute to improved endothelial function and lipid metabolism, though specific biomarkers warrant more thorough exploration.
The psychological and behavioral dimensions of yoga practice further potentiate its clinical value. Improved mindfulness and stress management may lead to healthier lifestyle choices, such as improved dietary habits, better sleep quality, and increased adherence to medical treatment plans—all of which profoundly affect cardiometabolic health. These indirect benefits, while harder to quantify, are integral to a holistic intervention model.
In summation, Wasityastuti et al.’s meta-analysis in PLOS Global Public Health substantiates yoga as a promising adjunct therapeutic option for adults with overweight and obesity aiming to improve critical cardiometabolic parameters. It robustly demonstrates reductions in systolic and diastolic blood pressure and favorable shifts in cholesterol components—effects that, although modest, are clinically meaningful on a population health scale. While more targeted research addressing dosage, practice standardization, and application to broader, more diverse patient groups is imperative, this study marks a significant advancement in integrating accessible exercise modalities into cardiometabolic disease prevention strategies.
As yoga continues its global proliferation beyond the realm of spiritual practice into mainstream health care, its potential role in reducing the burden of chronic cardiovascular and metabolic diseases appears increasingly viable. Incorporating yoga into public health initiatives for overweight and obese adults could represent a cost-effective, low-barrier strategy that complements traditional medical interventions—supporting both physical and psychological well-being. Future research tasked with elucidating precise biological mechanisms and optimizing intervention protocols will be instrumental in maximizing yoga’s therapeutic potential and its adoption in clinical practice guidelines worldwide.
Subject of Research: People with overweight or obesity
Article Title: Impact of yoga on cardiometabolic health in adults with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials
News Publication Date: 22-April-2026
Web References: https://doi.org/10.1371/journal.pgph.0006174
References: Wasityastuti W, Pramaningtyas MD, Wibowo RA, Adnan ML, Prabowo R, Tsurayya Z, et al. (2026) Impact of yoga on cardiometabolic health in adults with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials. PLOS Glob Public Health 6(4): e0006174.
Keywords: Yoga, Cardiometabolic Health, Overweight, Obesity, Blood Pressure, Lipids, Randomized Controlled Trials, Meta-analysis
